Drugs / CAL
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00051779 | — | breast cancer, metastatic neoplasm | Chugai Pharma USA | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CAL | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00051779 ↗ |
| Modality | Monoclonal antibody | “an investigational humanized monoclonal antibody (CAL) to the parathyroid hormone-related protein (PTHrP)” NCT00051779 ↗ |